tirzepatide the villages fl for Weight Loss Infinity Medical Institute at the
Description
People with GI sensitivity If you have a history of GI issues, whether from previous GLP-1 agonist use, conditions like IBS or GERD, or general digestive sensitivity, starting at the absolute lowest dose is critical
The effect of tirzepatide on morbidity and mortality in a high cardiovascular risk population living with obesity (without diabetes) will be assessed at the A Study of Tirzepatide on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO) trial
Retatrutide (Triple Agonist) Retatrutide is a first-in-class triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, producing the most profound metabolic effects seen in obesity research to date
Ozempic , which targets the GLP-1 receptor, can also support significant weight loss by reducing appetite and increasing satiety
To put this in context, it helps to look at what clinical trials show as typical, expected weight loss with these medications
